Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.61
-0.6500-1.41%
Post-market: 45.60-0.0100-0.02%19:59 EDT
Volume:8.50M
Turnover:388.68M
Market Cap:201.74B
PE:11.39
High:46.21
Open:46.17
Low:45.41
Close:46.26
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.73
T/O Rate:0.27%
Dividend:1.72
Dividend Rate:3.78%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.19
PE(LYR):12.60

Loading ...

Novo Nordisk call volume above normal and directionally bullish

TIPRANKS
·
Aug 25

Movement Alert|Novo-Nordisk A/S Rises 3.01% in Regular Trading, JPMorgan Raises Target Price to 275 DKK

Market Focus
·
Aug 25

Novo Nordisk Sales Growth Could Remain Flat This Year

Dow Jones
·
Aug 25

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Aug 25

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Aug 25

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

TIPRANKS
·
Aug 25

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 24

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Dow Jones
·
Aug 24

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

TIPRANKS
·
Aug 24

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

Novonesis Expects Results from Weight-Loss Drug Supplement Study in 2027

Reuters
·
Aug 20

Moderately bullish activity in Novo Nordisk with shares up 1.32%

TIPRANKS
·
Aug 20

Novo Nordisk Adds a New Early-Stage Obesity Drug to Its Pipeline

TIPRANKS
·
Aug 20

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Movement Alert|Novo-Nordisk A/S Rises 3.02% in Regular Trading, Launches Low-Dose Oral Weight Loss Drug Clinical Trial

Market Focus
·
Aug 19

Novo Nordisk testing lower doses of oral Wegovy, Reuters reports

TIPRANKS
·
Aug 19

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

Dow Jones
·
Aug 19

Novo Nordisk Launches Dosage Study for Oral Semaglutide

MT Newswires Live
·
Aug 19